- Track your favorite companies
- Receive email alerts for new filings
- Personalized dashboard of news and more
- Access all data and search results
- S-4/A Registration of securities issued in business combination transactions
- 5.1 Form of Legal Opinion of Loeb & Loeb LLP
- 10.13 Sponsored Research Agreement with Universitat Autonoma De Barcelona
- 10.14 Exclusive License with Universitat Autonoma De Barcelona and Institucio Catalana De Recerca I Estudis Avancats for the Cognition and Alzheimer's Related Inventions Covered by Uspto Application No.: 15/777,456
- 10.15 Exclusive License with Universitat Autonoma De Barcelona and Institucio Catalana De Recerca I Estudis Avancats for the Neuromuscular Related Inventions Covered by Uspto Application No.: 18/299,989
- 10.16 Non-exclusive License with University of Heidelberg, Germany for the Myotropic Aav Capsids Related Inventions Covered by Uspto Application No. 17/051,123
- 10.17 Exclusive License Agreement and Exclusive License and Manufacturing Agreement In Licensed Territories with Reliance Life Science Private Limited
- 10.18 Exclusive Sublicense License Agreement with Teleost Biopharmaceuticals, LLC (Az) for the Melanocortins Related Technologies Covered by Us Patent 9,441,013, Us Patent 10,329,326, Us Patent 9,290,539, Us Patent 9,539,301 and European Patent 3,177,737
- 23.2 Consent of Marcum LLP
- 23.3 Consent of Friedman LLP
- 23.4 Consent of BF Borgers Cpa PC, Independent Registered Public Accounting Firm to Anew
- 99.1 Consent of Edward Cong Wang to Be Named As a Director Nominee
- 99.2 Consent of Shalom Hirschman to Be Named As a Director Nominee
- 99.3 Consent of Jon Mcgarity to Be Named As a Director Nominee
- 99.4 Consent of Samuel Zentman to Be Named As a Director Nominee
- 99.5 Consent of Joseph Sinkule to Be Named As a Director Nominee
- Download Excel data file
- View Excel data file
- 16 Feb 24 424B3 Prospectus supplement
- 15 Feb 24 EFFECT Notice of effectiveness
- 12 Feb 24 S-4/A Registration of securities issued in business combination transactions (amended)
- 7 Feb 24 S-4/A Registration of securities issued in business combination transactions (amended)
-
1 Feb 24 S-4/A Registration of securities issued in business combination transactions (amended)
- 3 Jan 24 S-4/A Registration of securities issued in business combination transactions (amended)
- 4 Dec 23 S-4/A Registration of securities issued in business combination transactions (amended)
- 8 Nov 23 S-4/A Registration of securities issued in business combination transactions (amended)
- 17 Oct 23 S-4/A Registration of securities issued in business combination transactions (amended)
- 4 Aug 23 S-4 Registration of securities issued in business combination transactions
Exhibit 99.4
Consent to be Named as a Director Nominee
In connection with the filing by Redwoods Acquisition Corp. (the “Registrant”) of the Registration Statement on Form S-4 (the “Registration Statement”) with the Securities and Exchange Commission under the Securities Act of 1933, as amended (the “Securities Act”), I hereby consent, pursuant to Rule 438 under the Securities Act, to the references to my name in the Registration Statement and any and all amendments and supplements thereto, which indicate that I have accepted the nomination to become a director of the Registrant following the consummation of the business combination involving ANEW MEDICAL, INC. and the Registrant. I also consent to the filing of this consent as an exhibit to such Registration Statement and any and all amendments and supplements thereto.
Dated: January 26, 2024 | /s/ Samuel Zentman | |
Name: | Samuel Zentman |